TipRanks
Kura Oncology (DE:KUR)
FRANKFURT:KUR
Germany Market
KUR
Kura Oncology
RESEARCH TOOLSreports

Kura Oncology (KUR) Income Statement

8 Followers

Kura Oncology Income Statement

Last quarter (Q2 2026), Kura Oncology's total revenue was $20.87M, an increase of 36.54% from the same quarter last year. In Q2, Kura Oncology's net income was $-68.33M. See Kura Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 67.48M$ 53.88M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 67.42M$ 53.88M$ -849.00K$ 0.00$ 0.00
Operating Expenses
$ 371.06M$ 247.08M$ 164.96M$ 139.87M$ 131.26M
Depreciation and Amortization
$ 1.03M$ 848.00K$ 849.00K$ 759.00K$ 558.00K
EBITDA
$ -275.82M$ -169.50M$ -150.23M$ -134.85M$ -129.49M
Operating Income
$ -303.63M$ -193.19M$ -165.80M$ -139.87M$ -131.26M
Other Income/Expenses
$ 25.26M$ 21.23M$ 13.17M$ 4.03M$ 792.00K
Pretax Income
$ -278.37M$ -171.97M$ -152.63M$ -135.84M$ -130.47M
Net Income
$ -278.67M$ -173.98M$ -152.63M$ -135.84M$ -130.47M
Per Share Metrics
Basic EPS
$ -3.18$ -2.02$ -2.08$ -2.03$ -1.97
Diluted EPS
$ -3.18$ -2.02$ -2.08$ -2.03$ -1.97
Weighted Average Shares Outstanding
 87.68M 86.16M 73.23M 66.99M 66.35M
Weighted Average Shares Outstanding (Diluted)
 87.68M 86.16M 73.23M 66.99M 66.35M
Currency in USD

Kura Oncology Earnings and Revenue History